Additional information
Manufacturer |
Pharmatrans SANAQ |
---|---|
Quality |
EP, JP, USP |
Cas-No |
64044-51-5, 9005-25-8 |
Composition |
lactose, Starch |
Function |
Co-Processed |
Compendial Name |
Lactose Monohydrate (USP) / Maize Starch (USP) |
€0.00
Indicated to aid processing during manufacture, enhance the stability and effectiveness during manufacturing product process. Mixtures with high compressibility, superior diluition properties and fast disintegrating time. The purpose of the excipient is to aid processing during manufacture, enhance stability or bioavailability.
Co-Processed excipent based on mix of Lactose monohydrate and Starch. It is designed for direct compression providing help to improve tablet hardness, faster disintegration, and superior flowability. Disintegration of the tablets is independent from tablet hardness and lubricant level.
SANAQ SL 004® shows excellent and superior free powder flow compared with physical mixture in same ratio of components showing very poor flow properties.
SANAQ® SL 004 has an average PSD of 300 – 550 microns.
Manufacturer |
Pharmatrans SANAQ |
---|---|
Quality |
EP, JP, USP |
Cas-No |
64044-51-5, 9005-25-8 |
Composition |
lactose, Starch |
Function |
Co-Processed |
Compendial Name |
Lactose Monohydrate (USP) / Maize Starch (USP) |
SSG SANAQ®€0.00 |
Pharmatrans SANAQ | Select options |